Pharma Mar (OTCMKTS:PHMMF) Hits New 12-Month High – Still a Buy?

Pharma Mar, S.A. (OTCMKTS:PHMMF)’s share price reached a new 52-week high during trading on Thursday . The stock traded as high as $75.00 and last traded at $75.00, with a volume of 0 shares changing hands. The stock had previously closed at $75.00.

Analysts Set New Price Targets

Separately, Chardan Capital raised Pharma Mar to a “strong-buy” rating in a research report on Thursday, August 1st.

Pharma Mar Price Performance

The company has a current ratio of 2.55, a quick ratio of 2.01 and a debt-to-equity ratio of 0.14. The business’s 50-day moving average price is $60.04 and its 200 day moving average price is $42.61.

Pharma Mar Company Profile

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.